FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2780448 · Received October 10, 2012

Report

Report Number
2124215-2012-12591
Event Type
Malfunction
Date Received
October 10, 2012
Date of Event
September 14, 2012
Report Date
September 17, 2012
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THE DEVICE WAS EXPOSED TO SIMULATED HEART LOAD CONDITIONS, AND THE DEFIBRILLATION, PACING, AND SENSING FUNCTIONS WERE TESTED. THE DEVICE OPERATED APPROPRIATELY WITH NO INTERRUPTIONS IN THERAPY OUTPUT OR PROGRAMMER COMMUNICATION AT THE RETURNED PROGRAMMED SETTINGS. A SERIES OF ELECTRICAL TESTS WERE ALSO PERFORMED AND AGAIN, NORMAL DEVICE FUNCTION WAS OBSERVED. A REVIEW OF DEVICE MEMORY NOTED THE DEVICE HAD RECORDED ONE OR TWO FAULTS THAT WERE MOST LIKELY CAUSED BY THE USE OF ELECTROCAUTERY.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE WAS EXPLANTED, REPLACED, AND RETURNED DUE TO ELECTIVE REPLACEMENT/UPGRADE. NO FIELD ALLEGATIONS HAVE BEEN RECEIVED AGAINST FIT, FORM, OR FINISH OF THIS PRODUCT. THIS REPORT WAS CREATED DUE TO LABORATORY FINDINGS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 81 YR 1861| 5076| 4136| 1388TC| T125| 1831| 6945| E110| 4549| 0154| N161